BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9949905)

  • 1. [An immunohistochemical study of the expression of the epithelial antigen Ber-EP4 and other tissue-specific antigens in primary and metastatic brain tumors].
    Korshunov AG; Lakhteeva SV
    Arkh Patol; 1998; 60(6):41-7. PubMed ID: 9949905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HEA 125 and Ber EP4: two monoclonal anti-epithelial, non-cytokeratin antibodies distinguishing metastatic carcinomas from glial tumors.
    Gottschalk J; Jautzke G; Zimmer C; Cervós-Navarro J
    Clin Neuropathol; 1993; 12(2):68-72. PubMed ID: 7682900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of monoclonal antibodies to the epithelial membrane antigen in the diagnosis of human tumors].
    Delektorskaia VV; Ermilova VD; Baryshnikov AIu; Raĭkhlin NT
    Vopr Onkol; 1992; 38(5):562-71. PubMed ID: 1300755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial and melanoma antigens in gliosarcoma. An immunohistochemical study.
    Gottschalk J; Jautzke G; Schreiner C
    Pathol Res Pract; 1992 Feb; 188(1-2):182-90. PubMed ID: 1594490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
    Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
    Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine adenomatoid tumors: immunohistochemical characteristics with emphasis on Ber-EP4 immunoreactivity and distinction from adenocarcinoma.
    Otis CN
    Int J Gynecol Pathol; 1996 Apr; 15(2):146-51. PubMed ID: 8786204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
    Gleason BC; Nascimento AF
    Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cytokeratins in gliomas.
    Goswami C; Chatterjee U; Sen S; Chatterjee S; Sarkar S
    Indian J Pathol Microbiol; 2007 Jul; 50(3):478-81. PubMed ID: 17883112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
    Hsu FD; Nielsen TO; Alkushi A; Dupuis B; Huntsman D; Liu CL; van de Rijn M; Gilks CB
    Mod Pathol; 2002 Dec; 15(12):1374-80. PubMed ID: 12481020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology.
    Ikota H; Kinjo S; Yokoo H; Nakazato Y
    Acta Neuropathol; 2006 May; 111(5):475-82. PubMed ID: 16598485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical analysis of cellular infiltrates in primary glial and metastatic tumors in human brain.
    Kałuza J; Adamek D; Bujny T
    Patol Pol; 1993; 44(2):65-73. PubMed ID: 8367211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumors.
    Blümcke I; Müller S; Buslei R; Riederer BM; Wiestler OD
    Acta Neuropathol; 2004 Aug; 108(2):89-96. PubMed ID: 15146346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies on the prognostic significance of tumor infiltrating leukocytes in solid human tumors.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 2000; 20(3A):1759-68. PubMed ID: 10928105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
    Krahl D; Sellheyer K
    J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunochemical study of alpha-1 organospecific antigen in different sections of the brain and CNS tumors].
    Obukhov SK; Kasumova SIu; Kalashnikov VV
    Vopr Onkol; 1981; 27(2):61-4. PubMed ID: 6163253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression in childhood primary brain tumors of NY-ESO-1, a cancer/testis antigen: an immunohistochemical study.
    Bodey B; Bodey V; Siegel SE
    In Vivo; 2008; 22(1):83-7. PubMed ID: 18396787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration.
    Fetsch PA; Marincola FM; Filie A; Hijazi YM; Kleiner DE; Abati A
    Cancer; 1999 Feb; 87(1):37-42. PubMed ID: 10096358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.